secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2022-05-06T23:59:59+00:00
Accession:  0001193125-22-143077
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio raises $2.0M via registered direct offering and warrants
---------------------------------------------------------------------

- 3,646,690 shares at $0.55/share for gross proceeds of ~$2.0M.
- Concurrent warrants to purchase 3,646,690 shares at $0.7105, exercisable in 6 months.
- Closing expected on or about May 10, 2022, subject to customary conditions.
- Net proceeds for working capital and development of lead candidate LB1148.
- Ladenburg Thalmann acting as exclusive placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000119312522143077/0001193125-22-143077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000119312522143077/d292710d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-143077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer